# Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss

> **NCT00418730** · PHASE2 · COMPLETED · sponsor: **Neosil, Inc.** · enrollment: 180 (actual)

## Conditions studied

- Androgenetic Alopecia

## Interventions

- **DRUG:** tetrapeptide aldehyde proteasome inhibitor (NEOSH101)

## Key facts

- **NCT ID:** NCT00418730
- **Lead sponsor:** Neosil, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01
- **Primary completion:** 2007-10
- **Final completion:** 2008-04
- **Target enrollment:** 180 (ACTUAL)
- **Last updated:** 2008-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00418730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00418730, "Efficacy Study of Topical NEOSH101 to Treat Male Pattern Hair Loss". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00418730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*